Page last updated: 2024-08-22

rhenium and Leukemia

rhenium has been researched along with Leukemia in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's9 (81.82)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bräuchle, C; Czyz, M; Feil, F; Lesiak-Mieczkowska, K; Lorenz, IP; Sztiller-Sikorska, M; Wallek, AU; Wirth, S; Zernickel, A1
Bartkowiak, D; Bunjes, D; Dohr, D; Röttinger, EM; Wennauer, R1
Blumstein, N; Buchmann, I; Buck, AK; Bunjes, D; Döhner, H; Glatting, G; Kotzerke, J; Neumaier, B; Reske, SN; Ringhoffer, M; Schauwecker, P; Stilgenbauer, S; von Harsdorf, S; Wiesneth, M; Zenz, T1
Bunjes, D; Kotzerke, J; Scheinberg, DA1
Buchmann, I; Bunjes, D; Döhner, H; Glatting, G; Reske, SN; Schlenk, RF; Zenz, T1
Blumstein, NM; Buck, AK; Bunjes, D; Glatting, G; Kull, T; Neumaier, B; Reske, SN1
Bunjes, D; Glatting, G; Kotzerke, J; Neumaier, B; Reske, SN; Seitz, U1
Bergmann, L; Bunjes, D; Dohr, D; Duncker, C; Glatting, G; Kotzerke, J; Neumaier, B; Rentschler, M; Reske, SN; Seitz, U1
Bergmann, L; Buchmann, I; Buck, A; Bunjes, D; Döhner, H; Glatting, G; Kotzerke, J; Martin, H; Neumaier, B; Reske, SN; Seitz, U1
Dietrich, JW; Hermann, S; Hoelzer, D; Klein, SA; Martin, H1
Buchmann, I; Buck, A; Bunjes, D; Döhner, H; Glatting, G; Kotzerke, J; Martin, H; Rattat, D; Reske, SN; Seitz, U1

Reviews

1 review(s) available for rhenium and Leukemia

ArticleYear
Radioimmunoconjugates in acute leukemia treatment: the future is radiant.
    Bone marrow transplantation, 2005, Volume: 36, Issue:12

    Topics: Alpha Particles; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Beta Particles; Cell Adhesion Molecules; Clinical Trials as Topic; Dose-Response Relationship, Radiation; Humans; Immunoconjugates; Leukemia; Leukocyte Common Antigens; Quality Control; Radioimmunotherapy; Radioisotopes; Radiometry; Rhenium; Sialic Acid Binding Ig-like Lectin 3; Stem Cell Transplantation; Yttrium Radioisotopes

2005

Trials

5 trial(s) available for rhenium and Leukemia

ArticleYear
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
    British journal of haematology, 2005, Volume: 130, Issue:4

    Topics: Aged; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Antilymphocyte Serum; Antineoplastic Agents; Cell Adhesion Molecules; Female; Follow-Up Studies; Hematologic Diseases; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Depletion; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Radioimmunotherapy; Radioisotopes; Radiometry; Rhenium; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Yttrium Radioisotopes

2005
Targeted marrow irradiation with radioactively labeled anti-CD66 monoclonal antibody prior to allogeneic stem cell transplantation for patients with leukemia: results of a phase I-II study.
    Haematologica, 2006, Volume: 91, Issue:2

    Topics: Adult; Antigens, CD; Bone Marrow; Cell Adhesion Molecules; Hematopoietic Stem Cell Transplantation; Humans; Immunoconjugates; Leukemia; Middle Aged; Radioisotopes; Rhenium; Transplantation Conditioning; Transplantation, Homologous

2006
Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia.
    European journal of nuclear medicine, 1999, Volume: 26, Issue:10

    Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Adhesion Molecules; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Female; Flow Cytometry; Humans; Image Interpretation, Computer-Assisted; Injections, Intravenous; Isotope Labeling; Leukemia; Leukocytes; Male; Membrane Glycoproteins; Middle Aged; Quality Control; Radioimmunotherapy; Radioisotopes; Radiometry; Radiopharmaceuticals; Rhenium; Tissue Distribution

1999
Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:7

    Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, CD; Bone Marrow; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Recurrence; Rhenium; Survival Rate; Transplantation Conditioning; Whole-Body Irradiation

2001
Transplantation-related toxicity and acute intestinal graft-versus-host disease after conditioning regimens intensified with Rhenium 188-labeled anti-CD66 monoclonal antibodies.
    Blood, 2002, Mar-15, Volume: 99, Issue:6

    Topics: Acute Disease; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Cell Adhesion Molecules; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Radioimmunotherapy; Rhenium; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome

2002

Other Studies

5 other study(ies) available for rhenium and Leukemia

ArticleYear
Tautomerization of 2-nitroso-N-arylanilines by coordination as N,N'-chelate ligands to rhenium(I) complexes and the anticancer activity of newly synthesized oximine rhenium(I) complexes against human melanoma and leukemia cells in vitro.
    Journal of inorganic biochemistry, 2010, Volume: 104, Issue:7

    Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; Isomerism; Leukemia; Ligands; Melanoma; Rhenium

2010
Enhanced renal toxicity of total body irradiation combined with radioimmunotherapy.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2003, Volume: 179, Issue:10

    Topics: Adolescent; Adult; Animals; Creatinine; Dose Fractionation, Radiation; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Kidney; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Rats; Rhenium; Stem Cell Transplantation; Time Factors; Whole-Body Irradiation

2003
Dosimetry with (188)Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.i.
    Nuklearmedizin. Nuclear medicine, 2006, Volume: 45, Issue:3

    Topics: Antibodies, Monoclonal; Antigens, CD; Bone Marrow; Cell Adhesion Molecules; Humans; Image Processing, Computer-Assisted; Kidney; Leukemia; Liver; Radioisotopes; Radionuclide Imaging; Rhenium; Sensitivity and Specificity; Spleen; Tissue Distribution

2006
Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Adhesion Molecules; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Membrane Glycoproteins; Middle Aged; Phantoms, Imaging; Radioimmunotherapy; Radiometry; Rhenium; Technetium; Tissue Distribution; Transplantation Conditioning

2000
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
    Cancer biotherapy & radiopharmaceuticals, 2002, Volume: 17, Issue:2

    Topics: Adolescent; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Bone Marrow; Cell Adhesion Molecules; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Liver; Lung; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Rhenium; Survival Rate; Tissue Distribution; Transplantation Conditioning

2002